Jeff Yass’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,130
Closed -$31.2K 13572
2026
Q1
$31.2K Sell
17,130
-52,891
-76% -$90.5K ﹤0.01% 12756
2025
Q4
$135K Buy
70,021
+9,800
+16% +$19.6K ﹤0.01% 11253
2025
Q3
$126K Sell
60,221
-46,666
-44% -$105K ﹤0.01% 11410
2025
Q2
$255K Buy
106,887
+48,723
+84% +$142K ﹤0.01% 10698
2025
Q1
$168K Buy
58,164
+17,582
+43% +$54.6K ﹤0.01% 11113
2024
Q4
$127K Buy
+40,582
New +$141K ﹤0.01% 11149
2024
Q3
Sell
-2,913
Closed -$11.7K 12151
2024
Q2
$11.7K Buy
2,913
+719
+33% +$3.48K ﹤0.01% 11754
2024
Q1
$12.9K Buy
+2,194
New +$10.7K ﹤0.01% 11884
2023
Q3
Sell
-13,668
Closed -$149K 12152
2023
Q2
$149K Buy
+13,668
New +$162K ﹤0.01% 10584
2023
Q1
Sell
-2,416
Closed -$24.1K 12691
2022
Q4
$24.1K Sell
2,416
-1,045
-30% -$11.7K ﹤0.01% 11695
2022
Q3
$42K Buy
3,461
+2,594
+299% +$35.6K ﹤0.01% 12302
2022
Q2
$13K Buy
+867
New +$13K ﹤0.01% 12455
2020
Q2
Sell
-1,709
Closed -$17K 10224
2020
Q1
$17K Buy
+1,709
New +$23K ﹤0.01% 9965
2019
Q4
Sell
-906
Closed -$8K 9843
2019
Q3
$8K Sell
906
-2,658
-75% -$25.4K ﹤0.01% 10031
2019
Q2
$36K Buy
3,564
+2,658
+293% +$31.6K ﹤0.01% 9906
2019
Q1
$15K Buy
+906
New +$10.5K ﹤0.01% 8623
2018
Q4
Sell
-907
Closed -$11K 9077
2018
Q3
$11K Buy
+907
New +$12.2K ﹤0.01% 9041

Other funds holding DARE

Jeff Yass's DARE Position: Q2 2026 in Review

Jeff Yass sold out of Dare Bioscience (DARE) in Q2 2026, closing a stake of 17,130 shares — an estimated $31.2K sold.

Jeff Yass first reported a position in DARE in Q3 2018 and held it in 17 quarters. The position peaked at $255K in Q2 2025. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Jeff Yass reported no remaining Dare Bioscience position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 17,130 Dare Bioscience shares in Q2 2026, an estimated $31.2K.
  • Jeff Yass first reported a position in Dare Bioscience in Q3 2018 and held it in 17 quarters.
  • Jeff Yass's Dare Bioscience position peaked at $255K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.